In Regard to Sanford et al

To the Editor: We read with interest Sanford et al's report (1) on their prospective study examining fractionated radiation therapy (RT) for residual/recurrent benign meningioma after resection; we applaud the authors for being the first to conduct such a study and for demonstrating the integrity and courage to present their complications wholeheartedly. Although the 98% 10-year and 90% 15-year local control rates are impressive, we were particularly alarmed at the more than 20% stroke rate at the authors' median 17-year follow up (along with the near 60% rate of grade 2+ toxicity).

http://ift.tt/2EoQ8JR